Highlights

Cancer drug advances to phase II clinical trials

Cancer drug advances to phase II clinical trials

A New Zealand cancer drug developed by two Maurice Wilkins Centre investigators has reached the second phase of clinical tria...

read the full story

Partnerships boost business: MWC supports Auckland Clinical Studies (2013)

Partnerships boost business: MWC supports Auckland Clinical Studies (2013)

The Maurice Wilkins Centre provides world-class support for medical trials provider Auckland Clinical Studies, helping to cem...

read the full story

New chemistry transforms cancer vaccine (2013)

New chemistry transforms cancer vaccine (2013)

A new kind of chemistry that dramatically simplifies the manufacture of cancer vaccines was created this year by Honours stud...

read the full story

Stepping up the fight: The Tuberculosis Flagship (2013)

Stepping up the fight: The Tuberculosis Flagship (2013)

The Maurice Wilkins Centre is behind the launch of a national research network of ‘serious intellectual muscle’ that aims to ...

read the full story

New Zealand TB drug candidate selected (2012)

New Zealand TB drug candidate selected (2012)

In late 2012 a promising New Zealand compound targeting treatment-resistant tuberculosis (TB) was selected as a drug candidat...

read the full story

A licence to manufacture medicines (2012)

A licence to manufacture medicines (2012)

A licence to manufacture medicines has been granted to a University of Auckland facility that will produce the active ingredi...

read the full story

Dissecting drug side effects offers hope (2011)

Dissecting drug side effects offers hope (2011)

Researchers from the Maurice Wilkins Centre have discovered how a common class of medicines causes diabetes-like symptoms, an...

read the full story

Joining forces against infectious disease (2010)

Joining forces against infectious disease (2010)

The 2010 Superbugs Symposium convened by the Maurice Wilkins Centre brought together more than 350 medical professionals and ...

read the full story

Drug selection a milestone for spin-out (2010)

Drug selection a milestone for spin-out (2010)

In 2010 Maurice Wilkins Centre investigators Professors Bill Denny and Peter Shepherd selected a new anticancer drug candidat...

read the full story